Keystone Financial Group (Kentucky)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434K Sell
2,282
-75
-3% -$12.9K 0.03% 354
2026
Q1
$398K Sell
2,357
-1
-0% -$171 0.03% 338
2025
Q4
$398K Sell
2,358
-125
-5% -$20.3K 0.03% 294
2025
Q3
$400K Sell
2,483
-122
-5% -$16.7K 0.03% 271
2025
Q2
$339K Sell
2,605
-4
-0.2% -$491 0.03% 295
2025
Q1
$322K Sell
2,609
-71
-3% -$9.63K 0.03% 277
2024
Q4
$361K Buy
+2,680
New +$377K 0.04% 265
2022
Q3
– Sell
-1,996
Closed -$235K – 292
2022
Q2
$235K Sell
1,996
-17
-0.8% -$2.02K 0.05% 251
2022
Q1
$262K Sell
2,013
-31
-2% -$4.04K 0.04% 248
2021
Q4
$312K Buy
2,044
+47
+2% +$7.28K 0.05% 230
2021
Q3
$323K Sell
1,997
-267
-12% -$44.9K 0.06% 215
2021
Q2
$371K Buy
2,264
+46
+2% +$7.09K 0.07% 193
2021
Q1
$334K Sell
2,218
-608
-22% -$96.6K 0.07% 196
2020
Q4
$428K Sell
2,826
-111
-4% -$15.9K 0.09% 152
2020
Q3
$398K Sell
2,937
-355
-11% -$48.2K 0.1% 151
2020
Q2
$450K Buy
3,292
+263
+9% +$33.5K 0.12% 132
2020
Q1
$326K Buy
3,029
+626
+26% +$72.1K 0.11% 142
2019
Q4
$290K Buy
+2,403
New +$268K 0.08% 184
2019
Q3
– Sell
-1,931
Closed -$211K – 235
2019
Q2
$211K Buy
+1,931
New +$205K 0.07% 210

Other funds holding IBB

Keystone Financial Group (Kentucky)'s IBB Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) reduced its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2026, selling an estimated $12.9K and leaving 2,282 shares worth $434K. The position accounts for 0.03% of the portfolio, ranked #354.

Keystone Financial Group (Kentucky) first reported a position in IBB in Q2 2019 and has held it in 19 quarters since. The position peaked at $450K in Q2 2020. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 2,282 shares of iShares Biotechnology ETF worth $434K as of Q2 2026.
  • Keystone Financial Group (Kentucky) sold 75 iShares Biotechnology ETF shares in Q2 2026, an estimated $12.9K.
  • iShares Biotechnology ETF made up 0.03% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #354 holding.
  • Keystone Financial Group (Kentucky) first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 19 quarters since.
  • Keystone Financial Group (Kentucky)'s iShares Biotechnology ETF position peaked at $450K in Q2 2020.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.